A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males

NCT03335254 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Incomplete effect

Conditions

Hypogonadism
Hypogonadism, Male
Gonadal Disorders
Endocrine System Diseases
Testosterone Deficiency

Interventions

DRUG: TSX-011

Sponsor

TesoRx Pharma, LLC